Bioniz, LLC Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Bioniz, LLC is a small biotechnology company based in Irvine, California, focused on developing peptide-based therapeutics that aim to inhibit multiple cytokines simultaneously to address immuno-inflammatory diseases and cancer. The firm has advanced a clinical development program and has engaged in collaborations with pharmaceutical partners, including a partnership with Almirall. Its research has included programs such as BNZ-01 for conditions like CTCL and autoimmune diseases, and BNZ-1 for skin cancer and alopecia. 

A notable development in its history is the 2022 transaction where Equillium acquired Bioniz, signaling a transition within the biopharmaceutical landscape. The Irvine-based company operated as a research-focused entity with a small team pursuing peptide-based multi-cytokine inhibitors as potential therapies.

Sign up for free to view info

Company overview Employee directory